Letter to the Editor—Comment on “Erythropoietic Protoporphyria and Surgery: A Case of Successful Mastectomy With Perioperative Light Shielding Strategies Based on Light‐Induced Hemolytic Threshold Assessment”
Ingeborg de Rover, N Chantal Peltenburg, Johan C M Sweep, Janneke G Langendonk · 2026
Read Letter to the Editor—Comment on “Erythropoietic Protoporphyria and Surgery: A Case of Successful Mastectomy With Perioperative Light Shielding Strategies Based on Light‐Induced Hemolytic Threshold Assessment” by Ingeborg de Rover, N Chantal Peltenburg, Johan C M Sweep, Janneke G Langendonk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13555185.txt.
Description
Ingeborg de Rover and three colleagues write to the editor about light shielding during surgery for a rare light-sensitive disease in a 2026 letter. The disease, erythropoietic protoporphyria, loads the body with a compound that turns visible light toxic to skin and organs. The letter answers a case report on shielding for a mastectomy in such a patient. Risk planning, they stress, should rest on liver health and compound levels for each patient.
Three fronts matter: blocking light injury, avoiding liver-harming drugs and iron, and lowering the compound before surgery when needed. Their own cases include a home-built filter that cut operating light sharply and halved its blue share. Risk rises with liver trouble, long open surgery, strong lights, and high compound levels. Shielding alone usually suffices for short procedures.
Catalog record
| CREATOR | Ingeborg de Rover, N Chantal Peltenburg, Johan C M Sweep, Janneke G Langendonk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4996 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |